The world according to poly(ADP-ribose) polymerase (PARP)—update 2006

By Barth Eberhard   Radermacher Peter   Szabó Csaba  

Intensive Care Medicine, Vol. 32, Iss. 10, 2006-10 ,pp. : 1470-1474

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Trials of Poly(ADP-Ribose) Polymerase Inhibitors for Cancer Therapy: A Review

By  

Reviews on Recent Clinical Trials, Vol. 10, Iss. 4, 2015-12 ,pp. : 326-339

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP-ribose) polymerase-1 in high glucose-induced epithelial-mesenchymal transition during peritoneal fibrosis

By            

International Journal of Molecular Medicine, Vol. 29, Iss. 3, 2012-01 ,pp. : 472-478

Spandidos Publications

Access to resources Recommend Favorite

Topochemical models for the prediction of poly(ADP-ribose) polymerase inhibitory activity of indole-1-ones

By Dureja Harish  

Medicinal Chemistry Research, Vol. 16, Iss. 1, 2008-01 ,pp. : 15-27

Springer Publishing Company

Access to resources Recommend Favorite

Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation

By Soriano Francisco   Virág László   Szabó Csaba  

Journal of Molecular Medicine, Vol. 79, Iss. 8, 2001-08 ,pp. : 437-448

Springer Publishing Company

Access to resources Recommend Favorite